SEKINO, Yohei

論文

  1. Kobayashi G, Sentani K, Babasaki T, Sekino Y, Shigematsu Y, Hayashi T, Oue N, Teishima J, Matsubara A, Sasaki N, Yasui W.
    Claspin overexpression is associated with high-grade histology and poor prognosis in renal cell carcinoma.
    Cancer Sci. 2020 Jan 7. doi: 10.1111/cas.14299. [Epub ahead of print]
    Abstract:パブメドGoogle ScholarIF:
  2. Han X, Sekino Y, Babasaki T, Goto K, Inoue S, Hayashi T, Teishima J, Sakamoto N, Sentani K, Oue N, Yasui W, Matsubara A.
    Microtubule-associated Protein Tau (MAPT) is a promising independent prognostic marker and tumor suppressive protein in clear cell renal cell carcinoma.
    Urol Oncol. 2020 Mar 2. pii: S1078-1439(20)30051-X.
    Abstract:パブメドGoogle ScholarIF:
  3. Yamanaka R, Sekino Y, Babasaki T, Kitano H, Ikeda K, Goto K, Hieda K, Inoue S, Hayashi T, Teishima J, Aikata H, Chayama K, Sentani K, Yasui W, Matsubara A.
    Renal Metastasis from Primary Hepatocellular Carcinoma: A case report.
    Int Cancer Conf J, Mar 25, 2020, Epub.
    Abstract:パブメドGoogle ScholarIF:
  4. Sekino Y, Hagura T, Han X, Babasaki T, Goto K, Inoue S, Hayashi T, Teishima J, Shigeta M, Taniyama D, Kuraoka K, Sentani K, Yasui W,Matsubara A.
    PTEN is involved in sunitinib and sorafenib resistance in renal cell carcinoma.
    Anticancer Res 40:1943-1951, 2020.
    Abstract:パブメドGoogle ScholarIF:
  5. Sekino Y, Teishima J.
    Editorial comments to A rare case of carcinoma in situ originated in right retrocaval ureter successfully managed with laparoscopic procedure.
    IJU Case Reports, in press.
    Abstract:パブメドGoogle ScholarIF:
  6. Sekino Y, Han X, Babasaki T, Goto K, Inoue S, Hayashi T, Teishima J, Shiota M, Takeshima Y, Yasui W, Matsubara A.
    Microtubule-associated protein tau (MAPT) promotes bicalutamide resistance and is associated with survival in prostate cancer.
    Urol Oncol. 2020 May 16: S1078-1439(20): 30191-30195, 2020.
    Abstract:パブメドGoogle ScholarIF:
  7. Sekino Y, Han X, Babasaki T, Miyamoto S, Kitano H, Kobayashi G, Goto K, Inoue S, Hayashi T, Teishima J, Sakamoto N, Sentani K, Oue N, Yasui W, Matsubara A.
    TUBB3 is associated with high-grade histology, poor prognosis, p53 expression, and cancer stem cell markers in clear cell renal cell carcinoma.
    Oncology, in press.
    Abstract:パブメドGoogle ScholarIF:
  8. Teishima J, Hayashi T, Kitano H, Sadahide K, Sekino Y, Goto K, Inoue S, Honda Y, Sentani K, Awai K, Yasui W, Matsubara A.
    Impact of radiological morphology of clinical T1 renal cell carcinoma on the prediction of upstaging to pathological T3.
    Jpn J Clin Oncol. 2020 Feb 26. pii: hyz154. doi: 10.1093/jjco/hyz154. [Epub ahead of print]
    Abstract:パブメドGoogle ScholarIF:
  9. Mukai S, Shinmei S, Muto M, Hatayama T, Shikuma H, Miyamoto S, Fujii S, Sadahide K, Sekino Y, Hieda K, Inoue S, Hayashi T, Teishima J, Matsubara A.
    Refractory fistula of bladder repaired with transurethral cystoscopic injection of N‐butyl‐2‐cyanoacrylate.
    IJU Case Rep, 2019. https://doi.org/10.1002/iju5.12130
    Abstract:パブメドGoogle ScholarIF:
  10. Sekino Y, Oue N, Mukai S, Shigematsu Y, Goto K, Sakamoto N, Sentani K, Hayashi T, Teishima J, Matsubara A, Yasui W.
    Protocadherin B9 promotes resistance to bicalutamide and is associated with the survival of prostate cancer patients.
    Prostate. 2019 Feb;79(2):234-242. doi: 10.1002/pros.23728. Epub 2018 Oct 16.
    Abstract:パブメドGoogle ScholarIF:
  11. Sekino Y, Sakamoto N, Sentani K, Oue N, Teishima J, Matsubara A, Yasui W.
    miR-130b Promotes Sunitinib Resistance through Regulation of PTEN in Renal Cell Carcinoma.
    Oncology. 2019;97(3):164-172. doi: 10.1159/000500605. Epub 2019 Jun 13.
    Abstract:パブメドGoogle ScholarIF:
  12. Shikuma H, Inoue S, Hatayama T, Mukai S, Muto M, Miyamoto S, Sadahide K, Fujii S, Sekino Y, Goto K, Shinmei S, Hieda K, Hayashi T, Teishima J, Matsubara A.
    Pneumatosis cystoides intestinalis linked to sunitinib treatment for renal cell carcinoma.
    IJU Case Rep, 2019. https://doi.org/10.1002/iju5.12119
    Abstract:パブメドGoogle ScholarIF:
  13. Hatayama T, Sekino Y, Shikuma H, Mukai S, Muto M, Miyamoto S, Sadahide K, Fukuoka K, Fujii S, Goto K, Shinmei S, Hieda K, Inoue S, Hayashi T, Teishima J, Kuroda N, Sentani K, Yasui W, Matsubara A.
    Case of renal mucinous tubular and spindle cell carcinoma with high nuclear grade.
    IJU Case Rep 2 (4), 2019. https://doi.org/10.1002/iju5.12075
    Abstract:パブメドGoogle ScholarIF:
  14. Shigematsu Y, Oue N, Sekino Y, Sakamoto N, Sentani K, Uraoka N, Hayashi T, Teishima J, Matsubara A, Yasui W.
    SEC11A Expression Is Associated with Basal-Like Bladder Cancer and Predicts Patient Survival.
    Pathobiology 86:208-216, 2019.
    Abstract:パブメドGoogle ScholarIF:
  15. Sekino Y, Sakamoto N, Ishikawa A, Honma R, Shigematsu Y, Hayashi T, Sentani K, Oue N, Teishima J, Matsubara A, Yasui W.
    Transcribed ultraconserved region Uc.63+ promotes resistance to cisplatin through regulation of androgen receptor signaling in bladder cancer.
    Oncol Rep. 2019 Feb 28. doi: 10.3892/or.2019.7039. [Epub ahead of print]
    Abstract:パブメドGoogle ScholarIF:
  16. Teishima J, Hayashi T, Nagamatsu H, Shoji K, Shikuma H, Yamanaka R, Sekino Y, Goto K, Inoue S, Matsubara A.
    Fibroblast Growth Factor Family in the Progression of Prostate Cancer.
    J Clin Med.2019 Feb 4;8(2) doi:10.3390/jcm8020183.
    Abstract:パブメドGoogle ScholarIF:
  17. Sekino Y, Oue N, Koike Y, Shigematsu Y, Sakamoto N, Sentani K, Teishima J, Shiota M, Matsubara A, Yasui W.
    KIFC1 Inhibitor CW069 Induces Apoptosis and Reverses Resistance to Docetaxel in Prostate Cancer.
    J Clin Med. 2019 Feb 9;8(2).
    Abstract:パブメドGoogle ScholarIF:
  18. Sekino Y, Han X, Kawaguchi T, Babasaki T, Goto K, Inoue S, Hayashi T, Teishima J, Shiota M, Yasui W, Matsubara A.
    TUBB3 Reverses Resistance to Docetaxel and Cabazitaxel in Prostate Cancer.
    Int J Mol Sci. 2019 Aug 13;20(16). pii: E3936. doi: 10.3390/ijms20163936.
    Abstract:パブメドGoogle ScholarIF:
  19. Yohei Sekino, Naoya Sakamoto, Keisuke Goto, Ririno Honma, Yoshinori Shigematsu, Thang Pham Quoc, Kazuhiro Sentani, Naohide Oue, Jun Teishima, Fumi Kawakami, Jose A Karam, Kanishka Sircar,Akio Matsubara,and Wataru Yasui
    Uc.416 + A promotes epithelial-to-mesenchymal transition through miR-153 in renal cell carcinoma.
    BMC Cancer. 2018 Oct 4;18(1):952. doi: 10.1186/s12885-018-4863-y.
    Abstract:パブメドGoogle ScholarIF:
  20. Yukiko Honda , Yuko Nakamura, Keisuke Goto, Hiroaki Terada, Kazuhiro Sentani,Wataru Yasui, Yohei Sekino, Tetsutaro Hayashi, Jun Teishima, Akio Matsubara,Motonori Akagi, Tomoyo Fuji, Yasutaka Baba, Makoto Iida, and Kazuo Awai.
    Tubulocystic renal cell carcinoma: a review of literature focused on radiological findings for differential diagnosis.
    ABDOMINAL RADIOLOGY 2018 Jul-18 43(7) 1540-1545 10.1007/s00261-018-1643-8
    Abstract:パブメドGoogle ScholarIF:
  21. Honda Y, Goto K, Nakamura Y, Terada H, Sentani K, Yasui W, Sekino Y, Hayashi T, Teishima J, Matsubara A, Fuji T, Kaichi Y, Higaki T, Baba Y, Iida M, Awai K.
    Imaging features of papillary renal cell carcinoma with cystic change-dominant appearance in the era of the 2016 WHO classification.
    Abdom Radiol (NY). 2017 Jul;42(7):1850-1856.
    Abstract:パブメドGoogle ScholarIF:
  22. Honma R, Goto K, Sakamoto N, Sekino Y, Sentani K, Oue N, Yasui W.
    Expression and function of Uc.160+, a transcribed ultraconserved region, in gastric cancer
    Gastric Cancer. 2017 Nov;20(6):960-969.
    Abstract:パブメドGoogle ScholarIF:
  23. Pham QT, Oue N, Yamamoto Y, Shigematsu Y, Sekino Y, Sakamoto N, Sentani K, Uraoka N, Tiwari M, Yasui W.
    The Expression of BTS-2 Enhances Cell Growth and Invasiveness in Renal Cell Carcinoma.
    Anticancer Res. 2017 Jun;37(6):2853-2860.
    Abstract:パブメドGoogle ScholarIF:
  24. Mukai S, Oue N, Oshima T, Imai T, Sekino Y, Honma R, Sakamoto N, Sentani K, Kuniyasu H, Egi H, Tanabe K, Yoshida K, Ohdan H, Yasui W.
    Overexpression of PCDHB9 promotes peritoneal metastasis and correlates with poor prognosis in patients with gastric cancer.
    J Pathol. 2017 Sep;243(1):100-110.
    Abstract:パブメドGoogle ScholarIF:
  25. Sekino Y, Sakamoto N, Goto K, Honma R, Shigematsu Y, Sentani K, Oue N,Teishima J, Matsubara A, Yasui W.
    Transcribed ultraconserved region Uc.63+promotes resistance to docetaxel through regulation of androgen receptorsignaling in prostate cancer.
    Oncotarget. 2017 Oct 9;8(55):94259-94270.
    Abstract:パブメドGoogle ScholarIF:
  26. Sekino Y, Oue N, Shigematsu Y, Ishikawa A, Sakamoto N, Sentani K, Teishima J, Matsubara A, Yasui W.
    KIFC1 induces resistance to docetaxel and is associated with survival of patients with prostate cancer.
    Urol Oncol. 2017 Jan;35(1):31.e13-31.e20. doi: 10.1016/j.urolonc.2016.08.007.
    Abstract:パブメドGoogle ScholarIF:
  27. Y.Shigematsu, N.Oue, Y.Nishioka, N.Sakamoto, K.Sentani, Y.Sekino, S.Mukai, J.Teishima, A.Matsubara, W.Yasui.
    Overexpression of transmembrane protein BST-2 induces phosphorylation of Akt and Erk in bladder cancer.
    oncology letter(in press)
    Abstract:パブメドGoogle ScholarIF:
  28. Sekino Y, Mochizuki H, Kuniyasu H.
    A 49-year-old woman presenting with hepatoid adenocarcinoma of the urinary bladder: a case report.
    J Med Case Rep. 2013 Jan 9;7:12. doi: 10.1186/1752-1947-7-12.
    Abstract:パブメドGoogle ScholarIF:
  29. 吉野千城、関野陽平、森山浩之.腹腔鏡下尿管切石術を施行した2例.西日本泌尿器科.2016,78.29-35.
    Abstract:パブメドGoogle ScholarIF:
  30. 馬場崎隆志、井上省吾、小畠浩平、重松慶紀、関野陽平、北野弘之、永松弘孝、稗田圭介、郷力昭宏、正路晃一、林 哲太郎、梶原 充、亭島 淳、松原昭郎. 低強度体外衝撃波によるED治療効果の検討-陰茎プレチスモグラフィを用いた客観的評価.西日本泌尿器科.2016,
    Abstract:パブメドGoogle ScholarIF:
  31. 郷力昭宏, 馬場崎 隆志, 小畠浩平, 重松慶紀, 関野陽平, 北野弘之, 後藤景介, 永松弘孝, 稗田圭介, 正路晃一, 井上省吾, 梶原 充, 亭島 淳, 松原昭郎. 3.ハイリスク前立腺癌における術後PSA再発の予測因子. 泌尿器外科. 2015, 28(8), 1345-1347
    Abstract:パブメドGoogle ScholarIF:
  32. 関野洋平、長谷川泰久、三田耕司、井上洋二、松原昭郎,ソマトスタチン投与後に軽快した難治性乳糜腹水の1例,西日泌尿,2009,71,111-115
    Abstract:パブメドGoogle ScholarIF:
  33. 吉野 干城(島根県立中央病院 泌尿器科), 森山 浩之, 関野 陽平.腹腔鏡下尿管切石術を施行した2例,西日本泌尿器科(0029-0726)78巻1号 Page29-35(2016.01)
    Abstract:パブメドGoogle ScholarIF:
  34. 関野 陽平(市立三次中央病院 泌尿器科), 望月 英樹, 桐谷 玲子, 角西 雄一, 中原 満,福原 敏行.前立腺粘液腺癌の1例,泌尿器外科(0914-6180)25巻12号 Page2417-2420(2012.12)
    Abstract:パブメドGoogle ScholarIF:
  35. 関野 陽平(市立三次中央病院 泌尿器科), 稗田 圭介, 望月 英樹.肝・腎血管筋脂肪腫とリンパ脈管筋腫症を合併した結節性硬化症,臨床泌尿器科(0385-2393)66巻9号 Page693-697(2012.08)
    Abstract:パブメドGoogle ScholarIF:
  36. 関野 陽平(市立三次中央病院 泌尿器科), 望月 英樹, 桐谷 玲子, 角西 雄一, 中原 満.スニチニブ治療中に肺門部リンパ節転移から気管支出血をきたした転移性腎細胞癌,臨床泌尿器科(0385-2393)66巻5号 Page327-329(2012.04)
    Abstract:パブメドGoogle ScholarIF:
  37. 関野 陽平(市立三次中央病院 泌尿器科), 望月 英樹, 桐谷 玲子, 角西 雄一, 中原 満, 福原 敏行.遺伝子確定診断をした腎原発滑膜肉腫,臨床泌尿器科(0385-2393)66巻5号 Page323-325(2012.04)
    Abstract:パブメドGoogle ScholarIF:

受賞

2014年 第66回西日本泌尿器科学会総会 学術奨励賞▸ロボット支援前立腺全摘除術症例における腫瘍-被膜間距離の予測
2017年 広島大学成績優秀学生表彰
2018年 広島大学学生表彰